奥希替尼联合化疗成功治疗1例伴有EGFR突变和脑膜癌病的非小细胞肺癌患者 - Suppr

Suppr

超能文献

Successful Treatment with Osimertinib and Chemotherapy in a Non-Small Cell Lung Cancer Patient with EGFR Mutation and Meningeal Carcinomatosis.

作者信息

Yoshida Hironori, Ooi Masahiro, Kim Young Hak

机构信息

Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan.

出版信息

J Thorac Oncol. 2018 Nov;13(11):e219-e220. doi: 10.1016/j.jtho.2018.05.023.

DOI:10.1016/j.jtho.2018.05.023

PMID:30368410

Abstract

摘要

相似文献

Successful Treatment with Osimertinib and Chemotherapy in a Non-Small Cell Lung Cancer Patient with EGFR Mutation and Meningeal Carcinomatosis.奥希替尼联合化疗成功治疗1例伴有EGFR突变和脑膜癌病的非小细胞肺癌患者

J Thorac Oncol. 2018 Nov;13(11):e219-e220. doi: 10.1016/j.jtho.2018.05.023.

Efficacy of osimertinib in a patient with leptomeningeal metastasis and EGFR uncommon S768I mutation.奥希替尼在一名伴有软脑膜转移和EGFR罕见S768I突变患者中的疗效。

Lung Cancer. 2020 May;143:95-96. doi: 10.1016/j.lungcan.2020.03.016. Epub 2020 Mar 18.

Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase Inhibitors.奥希替尼治疗 EGFR 突变型非小细胞肺癌伴 EGFR 酪氨酸激酶抑制剂预处理性脑膜转移的疗效。

Target Oncol. 2018 Aug;13(4):501-507. doi: 10.1007/s11523-018-0581-2.

Clinical efficacy analysis of Osimertinib treatment for a patient with leptomeningeal metastasis of EGFR+ non-small cell lung cancer without the T790M mutation.奥希替尼治疗1例无T790M突变的EGFR+非小细胞肺癌软脑膜转移患者的临床疗效分析

Ann Palliat Med. 2019 Nov;8(5):525-531. doi: 10.21037/apm.2019.10.13.

T790M EGFR Mutation Detection in Cerebrospinal Fluid and Response to Osimertinib in a Lung Cancer Patient with Meningeal Carcinomatosis.脑脊液中T790M表皮生长因子受体突变检测及奥希替尼对一名肺癌脑膜转移患者的疗效

J Thorac Oncol. 2017 Sep;12(9):e138-e139. doi: 10.1016/j.jtho.2017.04.022.

Treatment of a NSCLC patient with osimertinib based on the detection of the EGFR T790M resistance mutation in cerebrospinal fluid.基于脑脊液中EGFR T790M耐药突变的检测，用奥希替尼治疗一名非小细胞肺癌患者。

Lung Cancer. 2017 Dec;114:111-112. doi: 10.1016/j.lungcan.2017.10.010. Epub 2017 Oct 28.

Detection of Meningeal Metastasis in the Cerebrospinal Fluid in Lung Adenocarcinoma: Case Report.肺腺癌脑脊液中脑膜转移的检测：病例报告

Clin Lung Cancer. 2020 Sep;21(5):e493-e496. doi: 10.1016/j.cllc.2020.04.010. Epub 2020 Apr 15.

Osimertinib in Patients With Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer and Leptomeningeal Metastases: The BLOOM Study.奥希替尼治疗表皮生长因子受体突变阳性非小细胞肺癌伴脑膜转移患者：BLOOM 研究。

J Clin Oncol. 2020 Feb 20;38(6):538-547. doi: 10.1200/JCO.19.00457. Epub 2019 Dec 6.

Acquired EGFR L718V Mutation as the Mechanism for Osimertinib Resistance in a T790M-Negative Non-Small-Cell Lung Cancer Patient.奥希替尼耐药的非小细胞肺癌患者中 L718V 获得性 EGFR 突变作为机制。

Target Oncol. 2019 Aug;14(4):369-374. doi: 10.1007/s11523-019-00652-6.

Osimertinib in the treatment of leptomeningeal disease in T790M-negative, epidermal growth factor receptor-mutated non-small cell lung cancer: a case report.奥希替尼治疗T790M阴性、表皮生长因子受体突变的非小细胞肺癌脑膜转移：一例报告

Chin Clin Oncol. 2019 Jun;8(3):29. doi: 10.21037/cco.2019.02.02. Epub 2019 Mar 4.

引用本文的文献

Osimertinib is associated with improved outcomes in pre-treated non-small cell lung cancer leptomeningeal metastases: A systematic review and meta-analysiss.奥希替尼与经治的非小细胞肺癌软脑膜转移患者预后改善相关：一项系统评价和荟萃分析。

Heliyon. 2024 Apr 17;10(9):e29668. doi: 10.1016/j.heliyon.2024.e29668. eCollection 2024 May 15.

Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance.奥希替尼耐药的表皮生长因子受体突变型非小细胞肺癌患者的治疗策略。

J Hematol Oncol. 2022 Dec 8;15(1):173. doi: 10.1186/s13045-022-01391-4.

Heterogeneity or transformation? A whack-a-mole case of EGFR-mutant lung adenocarcinoma and small cell carcinoma: A case report.异质性还是转化？EGFR 突变型肺腺癌和小细胞癌的“打地鼠”病例：一例报告。

Thorac Cancer. 2022 Aug;13(16):2394-2397. doi: 10.1111/1759-7714.14563. Epub 2022 Jul 6.

Treating disease progression with osimertinib in EGFR-mutated non-small-cell lung cancer: novel targeted agents and combination strategies.奥希替尼治疗 EGFR 突变型非小细胞肺癌的疾病进展：新型靶向药物和联合策略。

ESMO Open. 2021 Dec;6(6):100280. doi: 10.1016/j.esmoop.2021.100280. Epub 2021 Oct 9.

Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians' attitudes.奥希替尼治疗 T790M 阳性 NSCLC 患者进展后：一项临床医生态度的多中心研究。

Clin Transl Oncol. 2020 Jun;22(6):844-851. doi: 10.1007/s12094-019-02193-w. Epub 2019 Aug 7.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验